Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

Background: Despite the recent approval of new oral therapies for the treatment of multiple sclerosis (MS), a significant percentage of patients are still not free from disease activity. In view of the complex pathogenesis and the relapsing and progressive nature of MS, combination therapy, a classi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Innov Clin Neurosci
Asıl Yazarlar: Pouzol, Laetitia, Piali, Luca, Bernard, Claude CA, Martinic, Marianne M., Steiner, Beat, Clozel, Martine
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Matrix Medical Communications 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6538399/
https://ncbi.nlm.nih.gov/pubmed/31214480
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller